Psychometric properties of the Polish version of the

Generalized Anxiety Disorder 7-item scale anxiety employee wellbeing measurement invariance multigroup confirmatory factor analysis pandemics

Journal

International journal of occupational medicine and environmental health
ISSN: 1896-494X
Titre abrégé: Int J Occup Med Environ Health
Pays: Poland
ID NLM: 9437093

Informations de publication

Date de publication:
13 Nov 2023
Historique:
medline: 27 11 2023
pubmed: 22 9 2023
entrez: 22 9 2023
Statut: ppublish

Résumé

The COVID-19 outbreak is an example of a crisis that triggered an increase in generalized anxiety disorder. The study aims to validate the Polish version of the For assessing factor structure of the Polish version of the GAD-7, the data were collected from a sample of 821 adults employed in 4 economic sectors (health care, education, IT, public administration) during the initial phase of the COVID-19 pandemic in Poland (April 10-May 24, 2020). Due to differences in the severity of GAD symptoms across gender and age groups, the measurement invariance in these groups was tested. The results of a series of confirmatory factor analyses confirmed the unidimensionality of the GAD-7. The values of the composite reliability index and Cronbach's α showed that it is a reliable tool. The GAD levels demonstrated strong relationships with professional burnout, psychological distress, and psychological complaints. These relationships were stronger than the relationships between these factors and job satisfaction. Construct, metric and scalar invariance across gender and age groups were documented. Women experienced more severe symptoms of generalized anxiety disorder than men. Generalized anxiety disorder affected 28% of respondents. This study contributes evidence of the validation of the GAD among employees and also confirms the invariance depending on gender and age. The Polish version of the GAD-7 has good psychometric properties in a group of professionals and can be recommended for research and to be used in an occupational medicine practice, especially during crisis periods associated with the risk of developing a generalized anxiety disorder. Int J Occup Med Environ Health. 2023;36(4):493-504.

Identifiants

pubmed: 37737500
pii: 169372
doi: 10.13075/ijomeh.1896.02104
pmc: PMC10691419
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

493-504

Informations de copyright

This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Psychiatr Pol. 2023 Feb 28;57(1):223-235
pubmed: 37350726
J Anxiety Disord. 2014 Aug;28(6):547-52
pubmed: 24983795
JAMA. 2014 Jul 2;312(1):78-84
pubmed: 25058220
Global Health. 2020 Jul 6;16(1):57
pubmed: 32631403
Int J Environ Res Public Health. 2022 Sep 05;19(17):
pubmed: 36078815
BMC Psychiatry. 2021 Dec 15;21(1):627
pubmed: 34911485
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
J Affect Disord. 2019 Jun 1;252:114-121
pubmed: 30981054
Depress Anxiety. 2002;16(4):162-71
pubmed: 12497648
J Public Health (Oxf). 2020 Nov 23;42(4):672-678
pubmed: 32657323
Compr Psychiatry. 2021 Feb;105:152222
pubmed: 33388494
Cad Saude Publica. 2017 Sep 28;33(9):e00212716
pubmed: 28977285
Front Glob Womens Health. 2020 Dec 08;1:588372
pubmed: 34816164
Assessment. 2022 Dec;29(8):1901-1916
pubmed: 34372690
Psychol Trauma. 2020 May;12(4):331-335
pubmed: 32271070
Int J Environ Res Public Health. 2020 Dec 18;17(24):
pubmed: 33352940
Clin Psychol Psychother. 2013 Sep-Oct;20(5):456-64
pubmed: 22593009
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Front Psychol. 2019 Mar 13;10:284
pubmed: 30918490
J Affect Disord. 2017 Mar 01;210:338-344
pubmed: 28088111
Front Psychol. 2019 Aug 06;10:1713
pubmed: 31447721
Brain Behav. 2014 Jul;4(4):504-14
pubmed: 25161817
Psychiatr Pol. 2021 Jun 30;55(3):497-509
pubmed: 34460877
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110207
pubmed: 33338558
J Psychopathol Behav Assess. 2017 Mar;39(1):140-146
pubmed: 28260835
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326

Auteurs

Beata Aleksandra Basińska (BA)

Gdańsk University of Technology, Gdańsk, Poland (Faculty of Management and Economics, Department of Management).

Zuzanna Kwissa-Gajewska (Z)

SWPS University of Social Sciences and Humanities, Warsaw, Poland (Faculty of Psychology, Department of Health Psychology).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH